AcelRx Pharmaceuticals (ACRX) Posts Q1 Loss of 22c/Share
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Join SI Premium – FREE
AcelRx Pharmaceuticals (NASDAQ: ACRX) reported Q1 EPS of ($0.22), $0.01 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on AcelRx Pharmaceuticals (ACRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- OceanaGold to acquire Ausgold in a deal valued at A$776M
- Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
